BioSpace article on LexaGene antibiotic resistance testing

by | Aug 7, 2019 | Biothreat Detection

Home » Biothreat Detection » BioSpace article on LexaGene antibiotic resistance testing

The CDC and FDA AR Isolate Bank will provide information to LexaGene which will support the company’s diagnostics development and help address the serious issue of antibiotic resistance.

Read More at BioSpace

<a href="https://lexagene.com/author/lexagene-admin/" target="_self">LexaGene</a>

LexaGene

LexaGene develops fully automated, rapid molecular testing at the point-of-need for accurate pathogen detection in human clinical diagnostics, veterinary diagnostics, food safety, and other markets.

There is Even a Black Friday for Buying Capital Equipment

LexaGene’s MiQLab has direct benefits for veterinary clinics. Using LexaGene’s proven point-of-care diagnostics for evidence-based treatment of common bacterial infections found in companion animals may also result in cost savings.

Red Rover, Red Rover, Send PCR Testing Over

When thinking about how best to isolate a bacterium, scientists were often held to the standards of taking time to grow cultures in laboratories, a process involving days or weeks to simply prepare the sample for testing. In today’s everchanging world, LexaGene’s MiQLab™ now allows for samples to be captured at point-of-care, inserted into a cartridge, mixed with a reagent, and run through a testing system, shortening the time to result to hours instead of days.

Combating Supply Chain Woes: Decentralize Your In-Clinic Diagnostic Testing

More than ever, vet practices are looking for efficient and cost-effective methodologies to take control of these variables and manage costs.

Upcoming Events

No events in this category to show at this time.

Latest Resources


See how easy to use the MiQLabTM system is to detect pathogens and other molecular markers for a wide range of point-of-need applications.